WO2002036770A3 - Sequences polymorphes du gene humain abca1, leurs utilisations, les methodes et kits de detection - Google Patents
Sequences polymorphes du gene humain abca1, leurs utilisations, les methodes et kits de detection Download PDFInfo
- Publication number
- WO2002036770A3 WO2002036770A3 PCT/FR2001/003182 FR0103182W WO0236770A3 WO 2002036770 A3 WO2002036770 A3 WO 2002036770A3 FR 0103182 W FR0103182 W FR 0103182W WO 0236770 A3 WO0236770 A3 WO 0236770A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- abca1
- disease
- kits
- polymorphic
- abca1 gene
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Analytical Chemistry (AREA)
- Wood Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA002427436A CA2427436A1 (fr) | 2000-10-31 | 2001-10-12 | Sequences polymorphes du gene humain abca1, leurs utilisations, les methodes et kits de detection. |
EP01978530A EP1356102A2 (fr) | 2000-10-31 | 2001-10-12 | Sequences polymorphes du gene humain abca1, leurs utilisations, les methodes et kits de detection. |
AU2002210636A AU2002210636A1 (en) | 2000-10-31 | 2001-10-12 | Polymorphic sequences of the human ABCA1 gene, their uses, detection methods and kits |
JP2002539516A JP2004525611A (ja) | 2000-10-31 | 2001-10-12 | 多型ヒトabca1遺伝子の配列、それらの使用、検出方法およびキット |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0014037A FR2815970A1 (fr) | 2000-10-31 | 2000-10-31 | Sequences polymorphes du gene humain abca1, leurs utilisations, les methodes et kits de detection |
FR0014037 | 2000-10-31 | ||
US25410800P | 2000-12-11 | 2000-12-11 | |
US60/254,108 | 2000-12-11 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2002036770A2 WO2002036770A2 (fr) | 2002-05-10 |
WO2002036770A3 true WO2002036770A3 (fr) | 2003-09-04 |
Family
ID=26212711
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/FR2001/003182 WO2002036770A2 (fr) | 2000-10-31 | 2001-10-12 | Sequences polymorphes du gene humain abca1, leurs utilisations, les methodes et kits de detection |
Country Status (6)
Country | Link |
---|---|
US (1) | US20030056234A1 (fr) |
EP (1) | EP1356102A2 (fr) |
JP (1) | JP2004525611A (fr) |
AU (1) | AU2002210636A1 (fr) |
CA (1) | CA2427436A1 (fr) |
WO (1) | WO2002036770A2 (fr) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2002305019A1 (en) * | 2001-05-25 | 2002-12-09 | University Of British Columbia | Diagnostic methods for cardiovascular disease, low hdl-cholesterol levels, and high triglyceride levels |
WO2005110039A2 (fr) * | 2004-05-07 | 2005-11-24 | Applera Corporation | Polymorphismes genetiques associes a des maladies vasculaires, procedes de detection et utilisations de ceux-ci |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000055318A2 (fr) * | 1999-03-15 | 2000-09-21 | University Of British Columbia | Methodes et reactifs permettant de moduler les taux de cholesterol |
WO2000078970A1 (fr) * | 1999-06-17 | 2000-12-28 | Aventis Pharma S.A. | Acides nucleiques et proteines correspondant au gene abc1 humain |
WO2001030848A2 (fr) * | 1999-10-26 | 2001-05-03 | Aventis Pharma S.A. | Acides nucleiques du gene humain abc1 et leurs utilisations therapeutiques et diagnostiques |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6391589B1 (en) * | 1994-08-23 | 2002-05-21 | Human Genome Sciences, Inc. | Human chemokine beta-10 mutant polypeptides |
-
2001
- 2001-10-12 AU AU2002210636A patent/AU2002210636A1/en not_active Abandoned
- 2001-10-12 CA CA002427436A patent/CA2427436A1/fr not_active Abandoned
- 2001-10-12 EP EP01978530A patent/EP1356102A2/fr not_active Withdrawn
- 2001-10-12 JP JP2002539516A patent/JP2004525611A/ja active Pending
- 2001-10-12 WO PCT/FR2001/003182 patent/WO2002036770A2/fr not_active Application Discontinuation
- 2001-10-31 US US09/984,827 patent/US20030056234A1/en not_active Abandoned
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000055318A2 (fr) * | 1999-03-15 | 2000-09-21 | University Of British Columbia | Methodes et reactifs permettant de moduler les taux de cholesterol |
WO2000078970A1 (fr) * | 1999-06-17 | 2000-12-28 | Aventis Pharma S.A. | Acides nucleiques et proteines correspondant au gene abc1 humain |
WO2001030848A2 (fr) * | 1999-10-26 | 2001-05-03 | Aventis Pharma S.A. | Acides nucleiques du gene humain abc1 et leurs utilisations therapeutiques et diagnostiques |
Non-Patent Citations (11)
Title |
---|
BODZIOCH M ET AL: "THE GENE ENCODING ATP-BINDING CASSETTE TRANSPORTER 1 IS MUTATED IN TANGIER DISEASE", NATURE GENETICS, NEW YORK, NY, US, vol. 22, no. 4, August 1999 (1999-08-01), pages 347 - 351, XP000889766, ISSN: 1061-4036 * |
BROOKS-WILSON A ET AL: "MUTATIONS IN ABC1 IN TANGIER DISEASE AND FAMILIAL HIGH-DENSITY LIPOPROTEIN DEFICIENCY", NATURE GENETICS, NEW YORK, NY, US, vol. 22, no. 4, August 1999 (1999-08-01), pages 336 - 345, XP000889767, ISSN: 1061-4036 * |
LAWN R M ET AL: "THE TANGIER DISEASE GENE PRODUCT ABC1 CONTROLS THE CELLULAR APOLIPOPROTEIN-MEDIATED LIPID REMOVAL PATHWAY", JOURNAL OF CLINICAL INVESTIGATION, NEW YORK, NY, US, vol. 104, no. 8, October 1999 (1999-10-01), pages R25 - R31, XP000884782, ISSN: 0021-9738 * |
MARCIL M ET AL: "MUTATIONS IN THE ABC1 GENE IN FAMILIAL HDL DEFICIENCY WITH DEFECTIVE CHOLESTEROL EFFLUX", LANCET THE, LANCET LIMITED. LONDON, GB, vol. 354, no. 9187, 16 October 1999 (1999-10-16), pages 1341 - 1346, XP000877242, ISSN: 0140-6736 * |
MOTT STEPHANIE ET AL: "Decreased cellular cholesterol efflux is a common cause of familial hypoalphalipoproteinemia: Role of the ABCA1 gene mutations.", ATHEROSCLEROSIS, vol. 152, no. 2, October 2000 (2000-10-01), pages 457 - 468, XP001016219, ISSN: 0021-9150 * |
ORSO E ET AL: "TRANSPORT OF LIPIDS FROM GOLGI TO PLASMA MEMBRANE IS DEFECTIVE IN TANGIER DISEASE PATIENTS AND ABC1-DEFICIENT MICE", NATURE GENETICS, NEW YORK, NY, US, vol. 24, no. 2, February 2000 (2000-02-01), pages 192 - 196, XP000889762, ISSN: 1061-4036 * |
PULLINGER CLIVE R ET AL: "Analysis of hABC1 gene 5' end: Additional peptide sequence, promoter region, and four polymorphisms.", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, vol. 271, no. 2, 10 May 2000 (2000-05-10), pages 451 - 455, XP002176956, ISSN: 0006-291X * |
REMALEY A T ET AL: "HUMAN ATP-BINDING CASSETTE TRANSPORTER 1 (ABC1): GENOMIC ORGANIZATION AND IDENTIFICATION OF THE GENETIC DEFECT IN THE ORIGINAL TANGIER DISEASE KINDRED", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, NATIONAL ACADEMY OF SCIENCE. WASHINGTON, US, vol. 96, no. 22, 26 October 1999 (1999-10-26), pages 12685 - 12690, XP000877247, ISSN: 0027-8424 * |
RUST S ET AL: "TANGIER DISEASE IS CAUSED BY MUTATIONS IN THE GENE ENCODING ATP--BINDING CASSETTE TRANSPORTER 1", NATURE GENETICS, NEW YORK, NY, US, vol. 22, no. 4, August 1999 (1999-08-01), pages 352 - 355, XP000884993, ISSN: 1061-4036 * |
SANTAMARINA-FOJO SILVIA ET AL: "Complete genomic sequence of the human ABCA1 gene: Analysis of the human and mouse ATP-binding cassette A promoter.", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES, vol. 97, no. 14, 5 July 2000 (2000-07-05), July 5, 2000, pages 7987 - 7992, XP002176957, ISSN: 0027-8424 * |
WANG JIAN ET AL: "Common and rare ABCA1 variants affecting plasma HDL cholesterol.", ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, vol. 20, no. 8, August 2000 (2000-08-01), pages 1983 - 1989, XP002176955, ISSN: 1079-5642 * |
Also Published As
Publication number | Publication date |
---|---|
US20030056234A1 (en) | 2003-03-20 |
EP1356102A2 (fr) | 2003-10-29 |
AU2002210636A1 (en) | 2002-05-15 |
JP2004525611A (ja) | 2004-08-26 |
CA2427436A1 (fr) | 2002-05-10 |
WO2002036770A2 (fr) | 2002-05-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
LIU et al. | Denaturing HPLC-identified novel FBN1 mutations, polymorphisms, and sequence variants in Marfan syndrome and related connective tissue disorders | |
EP2500440A3 (fr) | Polymorphismes génétiques associés à l'infarctus du myocarde, procédés de détection et utilisations associées | |
WO2001029257A3 (fr) | Methodes relatives a une analyse typologique genetique et utilisation de celle-ci | |
EP0800406A2 (fr) | Dispositif et procedes de sterilisation par plasma | |
EP0955382A3 (fr) | Des polymorphismes associés à l'hypertension | |
CA2289872A1 (fr) | Reactions dependant de la cible faisant appel a des oligonucleotides formant des ponts avec des structures | |
CA2221318A1 (fr) | Ligands oligonucleotidiques ayant une affinite elevee pour les facteurs de croissance | |
CA2294516A1 (fr) | Proteines ikk-.beta., acides nucleiques et procedes | |
WO2001049097A3 (fr) | Secretase liee a la maladie d'alzheimer, substrats app et leurs utilisations | |
Conde et al. | Phospholipin, a novel heterodimeric phospholipase A2 from Pandinus imperator scorpion venom | |
AU6513598A (en) | Assaying nucleotides in solution using pna probes | |
WO2000066771A3 (fr) | Sequençage diagnostique par combinaison de clivage specifique et de spectrometrie de masse | |
DE69808743D1 (en) | Netrinrezeptoren | |
WO2004044163A3 (fr) | Procedes pour identifier les risques de melanomes et leurs traitements | |
Tarragó et al. | Identification by 19F NMR of traditional Chinese medicinal plants possessing prolyl oligopeptidase inhibitory activity | |
ATE245190T1 (de) | Robo: eine familie polypeptiden und nukleinesäuren wirksam in nervenzellleitung | |
CA2294566A1 (fr) | Proteines ikk-.alpha., acides nucleiques et procedes | |
Sarg et al. | Characterization of sequence variations in human histone H1. 2 and H1. 4 subtypes | |
WO2001068913A2 (fr) | Procede et systeme de detection d'acides nucleiques | |
WO2005027710A3 (fr) | Procedes d'identification de sujets a risque pour le melanome et traitements correspondants | |
WO2002036770A3 (fr) | Sequences polymorphes du gene humain abca1, leurs utilisations, les methodes et kits de detection | |
Lamontagne et al. | Modulation of human saposin B sphingolipid-binding specificity by alternative splicing. A study with saposin B-derived synthetic peptides. | |
WO2003054167A3 (fr) | Identification de sites polymorphes dans le gene humain mglur8 et utilisations associees | |
CA2261576A1 (fr) | Sondes permettant de detecter et d'identifier l'helicobacter pylori | |
CA2327587A1 (fr) | Methodes de traitement de l'hemophilie a au moyen d'anticorps humains anti-facteur viii humain |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2002539516 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2001978530 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2427436 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2002210636 Country of ref document: AU |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWP | Wipo information: published in national office |
Ref document number: 2001978530 Country of ref document: EP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 2001978530 Country of ref document: EP |